medical compliance

By David Richardson, Research Team Leader The Office of the Inspector General at Health and Human Services (OIG) has been highly focused recently on tracking and publicizing pharmaceutical companies' payments to thought leader physicians and clinical...

By Yanis Saradjian,Director of Consulting Our newly updated Fair-Market Value Benchmarking and Analysis service now provides medical, scientific and regulatory staff at life sciences companies with fair-market value benchmarks for thought leaders and influential...

By Casey Ferrell,Research Analyst Okay, it’s been almost 24 hours since ePharma Summit 2012 wrapped. Like a good holiday feast, if you did it right you’re probably still digesting the experience like I am. Day One’s symposia offered a more intimate...

By Casey Ferrell,Research Analyst The ePharma Summit 2012 kicked off with a full day of symposia on three tracks. I attended the Medical, Legal and Regulatory Policy Summit, and as I write this, my head is swimming with interesting facts, perspectives...

Six Tips to Help Build the Ideal Thought Leader Database As the industry awaits the release of the delayed Sunshine Act guidelines, pharmaceutical and medical device companies are benefiting from the extra time by reviewing current physician payment reporting...

New study provides process for calculating compliant fair-market value payments Although 100 percent of drug companies compensate key opinion leaders (KOLs) for their method of travel, only 60 percent do so for any preliminary work. And as mandatory public...

By Elio Evangelista,Director of Research In about five weeks, pharmaceutical, biotechnology and medical device companies will have to start compiling and aggregating data on their physician expenditures to meet the requirements spelled out in the Physician...

Medical affairs teams that demonstrate their performance to senior management with solid numbers gain invaluable negotiating power when it comes to budgets and new initiatives. However, in attempts to remain compliant, most companies have built strong firewalls...

As drug companies face requirements to report all spending on physician-related activity, relationships between thought leaders and drug manufacturers are feeling the strain. Aside from individual state laws requiring companies to report payments to physicians,...

The Sunshine Act, originally drafted in 2007, has been made law as part of the Patient Protection and Affordable Care Act. What passed was really a revised version of the original, of course, but the Sunshine Act is now the law of the land, and that will impact...